A Randomized, Open Label, Parallel Group, Study of the Impact of Aripiprazole (Abilify) Once Monthly Versus Standard of Care Oral Antipsychotic Medications on Changes in Brain Structure and Metabolism
Phase of Trial: Phase IV
Latest Information Update: 04 Jul 2017
At a glance
- Drugs Aripiprazole (Primary) ; Antipsychotics
- Indications Schizophrenia
- Focus Therapeutic Use
- Sponsors Otsuka America Pharmaceutical
- 09 Nov 2016 Planned primary completion date changed from 1 Sep 2016 to 1 Dec 2017.
- 02 Dec 2014 Status changed from not yet recruiting to recruiting, as reported by ClinicalTrials.gov record.
- 16 Sep 2014 New trial record